Epigenetic regulation of cell adhesion and cell communication pathways by the histone methyltransferase Ezh2 in human endothelial cells

被引：0
|
作者：
Dreger, H. [1 ]
Meiners, S. [2 ]
Weller, A. [1 ]
Ludwig, A. [1 ]
Stangl, V. [1 ]
Baumann, G. [1 ]
Stangl, K. [1 ]
机构：
[1] Charite, Dept Cardiol & Angiol, D-13353 Berlin, Germany
[2] Helmholtz Zentrum, Comprehens Pneumol Ctr CPC, Munich, Germany
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [21] The Histone Methyltransferase EZH2 is Required for Cell Growth in Diffuse Large B-cell Lymphoma
    Trojer, P.
    Garapaty, S.
    Lan, F.
    Balsubramanian, V.
    Chan, E.
    Hatton, C.
    Campbell, R.
    Cummings, R.
    Normant, E.
    Bryant, B.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 166 - 167
  • [22] Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A against non-small cell lung cancer cells
    Kikuchi, Junko
    Kinoshita, Ichiro
    Kikuchi, Eiki
    Shimizu, Yasushi
    Sakakibara-Konishi, Jun
    Oizumi, Satoshi
    Nishimura, Masaharu
    Dosaka-Akita, Hirotoshi
    CANCER RESEARCH, 2011, 71
  • [23] Histone methyltransferase Ezh2 negatively regulates NK cell terminal maturation and function
    Yu, Minghang
    Su, Ziyang
    Huang, Xuefeng
    Zhou, Yujie
    Zhang, Xulong
    Wang, Bingbing
    Wang, Zihan
    Liu, Yi
    Xing, Nianzeng
    Xia, Miaoran
    Wang, Xi
    JOURNAL OF LEUKOCYTE BIOLOGY, 2021, 110 (06) : 1033 - 1045
  • [24] Regulation of retinal ganglion cell gene expression by histone methyltransferase Ezh2 requires an interaction with G9a
    Xie, Jia
    Wang, Lucy
    Batsuuri, Khulan
    Cho, Kin-Sang
    Yang, Liu
    Chen, Dong Feng
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [25] Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells
    Nakagawa, Shigeki
    Sakamoto, Yasuo
    Okabe, Hirohisa
    Hayashi, Hiromitsu
    Hashimoto, Daisuke
    Yokoyama, Naomi
    Tokunaga, Ryuma
    Sakamoto, Keita
    Kuroki, Hideyuki
    Mima, Kosuke
    Beppu, Toru
    Baba, Hideo
    ONCOLOGY REPORTS, 2014, 31 (02) : 983 - 988
  • [26] Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells
    Kikuchi, Junko
    Takashina, Taichi
    Kinoshita, Ichiro
    Kikuchi, Eiki
    Shimizu, Yasushi
    Sakakibara-Konishi, Jun
    Oizumi, Satoshi
    Marquez, Victor E.
    Nishimura, Masaharu
    Dosaka-Akita, Hirotoshi
    LUNG CANCER, 2012, 78 (02) : 138 - 143
  • [27] Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
    Fiskus, Warren
    Wang, Yongchao
    Sreekumar, Arun
    Buckley, Kathleen M.
    Shi, Huidong
    Jillella, Anand
    Ustun, Celalettin
    Rao, Rekha
    Fernandez, Pravina
    Chen, Jianguang
    Balusu, Ramesh
    Koul, Sanjay
    Atadja, Peter
    Marquez, Victor E.
    Bhalla, Kapil N.
    BLOOD, 2009, 114 (13) : 2733 - 2743
  • [28] Control of endothelial cell function and arteriogenesis by MEG3:EZH2 epigenetic regulation of integrin expression
    Dunn-Davies, Hywel
    Dudnakova, Tatiana
    Nogara, Antonella
    Rodor, Julie
    Thomas, Anita C.
    Parish, Elisa
    Gautier, Philippe
    Meynert, Alison
    Ulitsky, Igor
    Madeddu, Paolo
    Caporali, Andrea
    Baker, Andrew
    Tollervey, David
    Mitic, Tijana
    MOLECULAR THERAPY NUCLEIC ACIDS, 2024, 35 (02):
  • [29] Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2
    Verma, Sharad K.
    Tian, Xinrong
    LaFrance, Louis V.
    Duquenne, Celine
    Suarez, Dominic P.
    Newlander, Kenneth A.
    Romeril, Stuart P.
    Burgess, Joelle L.
    Grant, Seth W.
    Brackley, James A.
    Graves, Alan P.
    Scherzer, Daryl A.
    Shu, Art
    Thompson, Christine
    Ott, Heidi M.
    Van Aller, Glenn S.
    Machutta, Carl A.
    Diaz, Elsie
    Jiang, Yong
    Johnson, Neil W.
    Knight, Steven D.
    Kruger, Ryan G.
    McCabe, Michael T.
    Dhanak, Dashyant
    Tummino, Peter J.
    Creasy, Caretha L.
    Miller, William H.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (12): : 1091 - 1096
  • [30] The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type
    Wang, Yemin
    Chen, Shary Yuting
    Karnezis, Anthony N.
    Colborne, Shane
    Dos Santos, Nancy
    Lang, Jessica D.
    Hendricks, William P. D.
    Orlando, Krystal A.
    Yap, Damian
    Kommoss, Friedrich
    Bally, Marcel B.
    Morin, Gregg B.
    Trent, Jeffrey M.
    Weissman, Bernard E.
    Huntsman, David G.
    JOURNAL OF PATHOLOGY, 2017, 242 (03): : 371 - 383
12345